Copyright Reports & Markets. All rights reserved.

(Post-pandemic Era)-Global Hormonal Contraceptive Market Segment Research Report 2022

Buy now

Table of Contents

    Global Hormonal Contraceptive Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global Hormonal Contraceptive Market by Value
          • 2.2.1 Global Hormonal Contraceptive Revenue by Type
          • 2.2.2 Global Hormonal Contraceptive Market by Value (%)
        • 2.3 Global Hormonal Contraceptive Market by Production
          • 2.3.1 Global Hormonal Contraceptive Production by Type
          • 2.3.2 Global Hormonal Contraceptive Market by Production (%)

        3. The Major Driver of Hormonal Contraceptive Industry

        • 3.1 Historical & Forecast Global Hormonal Contraceptive Demand
        • 3.2 Largest Application for Hormonal Contraceptive (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional Hormonal Contraceptive Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of Hormonal Contraceptive Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US Hormonal Contraceptive Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe Hormonal Contraceptive Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China Hormonal Contraceptive Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan Hormonal Contraceptive Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India Hormonal Contraceptive Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea Hormonal Contraceptive Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia Hormonal Contraceptive Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global Hormonal Contraceptive Average Price Trend

        • 12.1 Market Price for Each Type of Hormonal Contraceptive in US (2018-2022)
        • 12.2 Market Price for Each Type of Hormonal Contraceptive in Europe (2018-2022)
        • 12.3 Market Price for Each Type of Hormonal Contraceptive in China (2018-2022)
        • 12.4 Market Price for Each Type of Hormonal Contraceptive in Japan (2018-2022)
        • 12.5 Market Price for Each Type of Hormonal Contraceptive in India (2018-2022)
        • 12.6 Market Price for Each Type of Hormonal Contraceptive in Korea (2018-2022)
        • 12.7 Market Price for Each Type of Hormonal Contraceptive in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 Hormonal Contraceptive Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of Hormonal Contraceptive

        14. Hormonal Contraceptive Competitive Landscape

        • 14.1 Ansell Limited
          • 14.1.1 Ansell Limited Company Profiles
          • 14.1.2 Ansell Limited Product Introduction
          • 14.1.3 Ansell Limited Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 Bayer AG
          • 14.2.1 Bayer AG Company Profiles
          • 14.2.2 Bayer AG Product Introduction
          • 14.2.3 Bayer AG Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Church and Dwight Co
          • 14.3.1 Church and Dwight Co Company Profiles
          • 14.3.2 Church and Dwight Co Product Introduction
          • 14.3.3 Church and Dwight Co Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Johnson and Johnson
          • 14.4.1 Johnson and Johnson Company Profiles
          • 14.4.2 Johnson and Johnson Product Introduction
          • 14.4.3 Johnson and Johnson Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 Mayer Laboratories
          • 14.5.1 Mayer Laboratories Company Profiles
          • 14.5.2 Mayer Laboratories Product Introduction
          • 14.5.3 Mayer Laboratories Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Merck and Co
          • 14.6.1 Merck and Co Company Profiles
          • 14.6.2 Merck and Co Product Introduction
          • 14.6.3 Merck and Co Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Mylan N.V.
          • 14.7.1 Mylan N.V. Company Profiles
          • 14.7.2 Mylan N.V. Product Introduction
          • 14.7.3 Mylan N.V. Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives
        • 14.8 Pfizer
          • 14.8.1 Pfizer Company Profiles
          • 14.8.2 Pfizer Product Introduction
          • 14.8.3 Pfizer Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.8.4 Strategic initiatives
        • 14.9 Teva Pharmaceutical Industries
          • 14.9.1 Teva Pharmaceutical Industries Company Profiles
          • 14.9.2 Teva Pharmaceutical Industries Product Introduction
          • 14.9.3 Teva Pharmaceutical Industries Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.9.4 Strategic initiatives
        • 14.10 The Female Health Company
          • 14.10.1 The Female Health Company Company Profiles
          • 14.10.2 The Female Health Company Product Introduction
          • 14.10.3 The Female Health Company Hormonal Contraceptive Sales, Revenue (2018-2022)
          • 14.10.4 Strategic initiatives
        • 14.11 Organon International
        • 14.12 Afaxys

        15. Conclusion

          16. Methodology and Data Source

          Summary

          The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

          2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

          According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

          Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Hormonal Contraceptive Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Hormonal Contraceptive industry at home and abroad, estimate the overall market scale of the Hormonal Contraceptive industry and the market share of major countries, Hormonal Contraceptive industry, and study and judge the downstream market demand of Hormonal Contraceptive through systematic research, Analyze the competition pattern of Hormonal Contraceptive, so as to help solve the pain points of various stakeholders in Hormonal Contraceptive industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

          Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Hormonal Contraceptive Market by XYZResearch Include
          USA
          Europe
          China
          Japan
          India
          Korea
          Southeast Asia
          Competitive Analysis; Who are the Major Players in Hormonal Contraceptive Market?
          Ansell Limited
          Bayer AG
          Church and Dwight Co
          Johnson and Johnson
          Mayer Laboratories
          Merck and Co
          Mylan N.V.
          Pfizer
          Teva Pharmaceutical Industries
          The Female Health Company
          Organon International
          Afaxys
          Major Type of Hormonal Contraceptive Covered in XYZResearch report:
          Oral Contraceptive Pills
          Injectable Birth Control
          Emergency Contraceptive Pills
          Vaginal Rings
          Transdermal Patches
          Application Segments Covered in XYZResearch Market
          Hospitals
          Household
          Clinics

          For any other requirements, please feel free to contact us and we will provide you customized report.

          Buy now